ED tool to help prevent stroke in atrial fibrillation
Part of Heart & circulation clinical trials.
This study tests an electronic decision-support tool used in the emergency department (ED) to help clinicians choose the safest way to prevent stroke when atrial fibrillation is newly found. It may help by improving how quickly and consistently stroke-prevention treatment is considered.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are over 18 and were diagnosed with atrial fibrillation (or a type that comes and goes) during an ED visit.
- Your ED visit happened between January 11, 2022 and December 31, 2025.
- You are not currently pregnant.
- You do not have certain bleeding or blood-clotting problems (like very low platelets or serious uncontrolled bleeding).
- You do not have major severe problems with liver or kidneys.
- You were not transferred from another hospital, you were not leaving against medical advice, and you were not discharged from the ED with stroke/death/hospitalization during that same visit.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a computer tool that helps doctors decide if you need a blood thinner to lower your stroke risk. If you have atrial fibrillation (irregular heartbeat) and haven't been prescribed a blood thinner yet, this might help protect you.
This trial tests a web-based decision aid that helps people with atrial fibrillation (AF) decide about stroke-prevention treatment, such as blood thinners. It may help you feel more confident and make safer choices by showing options at the right time after diagnosis.
This study tests a shared decision-making tool to help Black and White patients with atrial fibrillation choose the right blood thinner to prevent strokes. It aims to make sure everyone gets equal care.
This trial looks at ways to help people with atrial fibrillation lower their risk of stroke, premature death, and worsening memory. It may help by identifying which prevention approach works best for a broader community of patients.
This trial tests whether an AI tool can help find hidden atrial fibrillation (an irregular heartbeat that can cause stroke) after a stroke. If you are hospitalized for a stroke, the AI may flag you for extra heart monitoring, which could lead to better treatment and fewer future strokes.
This trial tests an early treatment approach for people who had a recent ischemic stroke (a stroke caused by a blocked blood vessel) and have an irregular heart rhythm called atrial fibrillation (AF). It aims to lower the chance of having another stroke by treating AF as early as possible after the stroke.
Hear when a new Atrial fibrillation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.